[ESG 점검] 파마리서치, 성장에 가려진 환경 관리 리스크

Pharma Research's 53% production surge reveals a critical ESG reporting gap: water consumption jumped 42.5% and pollution rose across metrics despite efficiency improvements, exposing why boiler upgrades alone cannot offset expansion-driven environmental burdens. As regulators increasingly scrutinize whether sustainability reports reflect genuine control or merely optimized metrics, the company's compliance violations underscore that scaling manufacturers must embed environmental management into production planning from inception—not as reactive afterthoughts.